Synthetic Bacteria Help Treat Phenylketonuria in Mice
The genetically engineered probiotic, already in clinical trials, may ease patients’ strict dietary regimes.
Synthetic Bacteria Help Treat Phenylketonuria in Mice
Synthetic Bacteria Help Treat Phenylketonuria in Mice

The genetically engineered probiotic, already in clinical trials, may ease patients’ strict dietary regimes.

The genetically engineered probiotic, already in clinical trials, may ease patients’ strict dietary regimes.

rare diseases, cell & molecular biology, disease & medicine
Synthetic Cannabinoid K2 Overdoses Are Rampant. Here’s Why.
Synthetic Cannabinoid K2 Overdoses Are Rampant. Here’s Why.
Ashley Yeager | Aug 17, 2018
NIDA pharmacologist Michael Baumann explains how “unscrupulous vendors” hijacked compounds used in neuroscience and turned them into dangerous drugs.
Image of the Day: Revved Up
Image of the Day: Revved Up
Sukanya Charuchandra | Aug 16, 2018
Progesterone helps in the transportation of eggs within the mouse reproductive system.
Reprogrammed Müller Glia Restore Vision in Mice
Reprogrammed Müller Glia Restore Vision in Mice
Ashley Yeager | Aug 15, 2018
A double gene-transfer therapy transformed the non-neuronal cells into rod photoreceptors in the retinas of animal models of congenital blindness.
Vaping Damages Immune Cells, Researchers Find
Vaping Damages Immune Cells, Researchers Find
Catherine Offord | Aug 14, 2018
A small, in vitro study concludes that e-cigarette vapor harms macrophages taken from human lung tissue.
Q&A: Anthony Fauci Describes an Experimental Ebola Treatment
Q&A: Anthony Fauci Describes an Experimental Ebola Treatment
Shawna Williams | Aug 14, 2018
The monoclonal antibody, known as mAb114, is likely to be used in the current Ebola outbreak in DRC.
Jury Finds Monsanto’s Roundup Responsible for Man’s Cancer
Jury Finds Monsanto’s Roundup Responsible for Man’s Cancer
Sukanya Charuchandra | Aug 13, 2018
A San Francisco court levels $289 Million in damages against the pesticide maker.
FDA Approves Oral Drug for Fabry Disease
FDA Approves Oral Drug for Fabry Disease
Ashley Yeager | Aug 13, 2018
The medicine increases the activity of a deficient enzyme in certain patients with the condition.
Studies Unable to Reproduce Results of Two Diabetes Papers
Studies Unable to Reproduce Results of Two Diabetes Papers
Anna Azvolinsky | Aug 10, 2018
The original work found that an anti-malaria drug or the neurotransmitter GABA could increase the number of insulin-producing pancreatic cells in mice.
First RNAi Therapy Approved by FDA
First RNAi Therapy Approved by FDA
Kerry Grens | Aug 10, 2018
Alnylam’s patisiran interferes with the production of a mutated protein present in people with hereditary transthyretin amyloidosis.